initial public offerings (IPOs) trading on American exchanges

Monday, April 12, 2021

VectivBio (VECT) began trading on the Nasdaq on Fri 9 Apr 21

VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for treatments of severe rare conditions. 
  • Sector(s): Healthcare
  • Industry: Biotechnology
  • Full Time Employees: 42
  • Incorporated in 2019
  • Headquartered in Basel, Switzerland
VectivBio priced 7.5 mln shares IPO at $17.00 per share, at the midpoint of the $16-18 expected range

No comments:

Post a Comment